Photo taken from sbradioterapia.com.
Jun 19, 2024, 12:18
Gustavo Viani: SABR produced excellent local control
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo, recently posted on X:
“SABR produced excellent local control with less toxic effects in oligo Mets and progressive GY cancer
DESIGN Retro pooled analysis 5 hospitals (Canada and USA)
with oligometastatic/oligoprogressive GY treated SABR
LR, DR, chemotherapy-free survival (CFS), OS
RESULTS
215 patient with 320 lesions
Median FU: 18.5 m
cancer: endometrium (common), ovary, cervix, vulva/vagina
LR:
◦1 y: 13.7%/5 y: 18.5% DR
◦1 y: 48.5% /5 y: 73.1% OS:
◦1 y: 75.7% /5 y: 33.1%
Median CFS: 21.7 m.”
Source: Gustavo Viani/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 19, 2024, 17:09
Dec 19, 2024, 17:05
Dec 19, 2024, 17:01
Dec 19, 2024, 16:53
Dec 19, 2024, 16:50
Dec 19, 2024, 16:42
Dec 19, 2024, 16:41